Alpine Immune Sciences: Funding, Investors & Team (Sep 2026)
Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions. It was founded on January 23, 2015, and is based in Seattle, Washington.
Alpine Immune Sciences has raised $341M across 3 funding rounds on record, the most recent an undisclosed round of $150M announced in Nov 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alpine Immune Sciences Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Alpine Immune Sciences Funding Rounds
Alpine Immune Sciences raised $91.0M in a Post-IPO Equity announced in Sep 2021.
1 years later, a Post-IPO Equity of $100M was announced in Sep 2022.
1.2 years later, an undisclosed round of $150M was announced in Nov 2023.
Alpine Immune Sciences Founders and Leadership Team
Contact details for the Alpine Immune Sciences team: 2 of 2 have an email address on file.
Start 14-day free trial →Alpine Immune Sciences Funding Compared to Other Biotechnology Startups
Alpine Immune Sciences' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alpine Immune Sciences in Biotechnology and Seattle
Companies Similar to Alpine Immune Sciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Alpine Immune Sciences Funding FAQs
What does Alpine Immune Sciences do?
Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions. It was founded on January 23, 2015, and is based in Seattle, Washington.
How much funding has Alpine Immune Sciences raised?
Alpine Immune Sciences has raised $341M across 3 rounds on record. The most recent is an undisclosed round of $150M announced in Nov 2023.
When did Alpine Immune Sciences last raise funding?
Alpine Immune Sciences' most recent funding round on record is an undisclosed round of $150M, announced in Nov 2023.
Who founded Alpine Immune Sciences?
FundedIQ lists Mitchell Gold (Founder) at Alpine Immune Sciences.
Who is the CEO of Alpine Immune Sciences?
Gold Mitchell is listed as CEO at Alpine Immune Sciences.
Where is Alpine Immune Sciences headquartered?
Alpine Immune Sciences is based in Seattle, Washington, United States.
How many employees does Alpine Immune Sciences have?
Alpine Immune Sciences is in the 101-250 employee band.
How does Alpine Immune Sciences' funding compare to other Biotechnology startups?
Alpine Immune Sciences' latest round of $150M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Alpine Immune Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alpine Immune Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.